GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vanta Bioscience Ltd (BOM:540729) » Definitions » ROA %

Vanta Bioscience (BOM:540729) ROA % : -4.84% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Vanta Bioscience ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Vanta Bioscience's annualized Net Income for the quarter that ended in Sep. 2024 was ₹-41.38 Mil. Vanta Bioscience's average Total Assets over the quarter that ended in Sep. 2024 was ₹855.21 Mil. Therefore, Vanta Bioscience's annualized ROA % for the quarter that ended in Sep. 2024 was -4.84%.

The historical rank and industry rank for Vanta Bioscience's ROA % or its related term are showing as below:

BOM:540729' s ROA % Range Over the Past 10 Years
Min: -7.8   Med: 0.13   Max: 2.29
Current: -4.52

During the past 8 years, Vanta Bioscience's highest ROA % was 2.29%. The lowest was -7.80%. And the median was 0.13%.

BOM:540729's ROA % is ranked better than
50.44% of 226 companies
in the Medical Diagnostics & Research industry
Industry Median: -4.645 vs BOM:540729: -4.52

Vanta Bioscience ROA % Historical Data

The historical data trend for Vanta Bioscience's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vanta Bioscience ROA % Chart

Vanta Bioscience Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROA %
Get a 7-Day Free Trial 2.29 0.76 0.12 -7.80 -2.72

Vanta Bioscience Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.20 -9.31 -1.27 -4.19 -4.84

Competitive Comparison of Vanta Bioscience's ROA %

For the Diagnostics & Research subindustry, Vanta Bioscience's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vanta Bioscience's ROA % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vanta Bioscience's ROA % distribution charts can be found below:

* The bar in red indicates where Vanta Bioscience's ROA % falls into.


;
;

Vanta Bioscience ROA % Calculation

Vanta Bioscience's annualized ROA % for the fiscal year that ended in Mar. 2024 is calculated as:

ROA %=Net Income (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=-23.159/( (847.091+853.966)/ 2 )
=-23.159/850.5285
=-2.72 %

Vanta Bioscience's annualized ROA % for the quarter that ended in Sep. 2024 is calculated as:

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-41.376/( (853.966+856.452)/ 2 )
=-41.376/855.209
=-4.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Sep. 2024) net income data. ROA % is displayed in the 30-year financial page.


Vanta Bioscience  (BOM:540729) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=-41.376/855.209
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-41.376 / 20.61)*(20.61 / 855.209)
=Net Margin %*Asset Turnover
=-200.76 %*0.0241
=-4.84 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Vanta Bioscience ROA % Related Terms

Thank you for viewing the detailed overview of Vanta Bioscience's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vanta Bioscience Business Description

Traded in Other Exchanges
N/A
Address
No. 02/G/308/G, Umajay Complex, No. 3/FF/SF/1-20-248, Rasoolpura, Secunderabad, TG, IND, 500003
Vanta Bioscience Ltd is a full-service preclinical contract research organization. It is engaged in the provision of testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation services.

Vanta Bioscience Headlines

No Headlines